找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Drug Target miRNA; Methods and Protocol Marco F. Schmidt Book 2017 Springer Science+Business Media, LLC, part of Springer Nature 2017 drug

[复制链接]
楼主: 根深蒂固
发表于 2025-3-23 13:08:15 | 显示全部楼层
To Play by the Rules of the Gameical association of miRNA inhibitors and their targets in the context of the Argonaute complex in vivo, providing unprecedented insight into the physiological interactions of anti-miRs and the miRNA machinery.
发表于 2025-3-23 14:45:54 | 显示全部楼层
,Einwendungsmöglichkeiten des Zahnarztes,termine if a compound is able to impair the loading of miRNAs on AGO2 protein. Here, we describe these two methodologies that we recently used to select a specific compound able to interfere with the AGO2 functional activity and able to improve the retinoic acid-dependent myeloid differentiation of leukemic cells.
发表于 2025-3-23 19:20:52 | 显示全部楼层
发表于 2025-3-24 02:00:12 | 显示全部楼层
发表于 2025-3-24 03:00:59 | 显示全部楼层
发表于 2025-3-24 08:21:27 | 显示全部楼层
发表于 2025-3-24 13:30:41 | 显示全部楼层
Surface Plasmon Resonance: A Useful Strategy for the Identification of Small Molecule Argonaute 2 Pr the film, monitored in real time as a change in the position of the dip in reflected intensity. Since SPR detects mass, the technique is label-free..Here, we describe the use of SPR techniques to study the interaction between Argonaute 2 and small molecular compounds selected by means of high-throughput docking screening.
发表于 2025-3-24 18:12:58 | 显示全部楼层
发表于 2025-3-24 19:42:35 | 显示全部楼层
Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOsr lower molecular weight and, thus, more drug-like chemical structure, the novel inhibitor class may show better pharmacokinetic properties than reported oligonucleotide inhibitors, enabling them for potential therapeutic use.
发表于 2025-3-25 00:14:55 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-30 01:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表